Gray Zone Lymphoma (GZL) with Features Intermediate between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): A Pathologic Consensus Study with Patient Outcomes and Prognostication across 15 North American Centers
Abstract
Introduction: GZL is described as sharing features with both cHL and DLBCL. It was first described in 2005 and included in the 2008 and 2016 WHO classifications. However, there remains complexity in establishing diagnosis, determining optimum therapy and delineating prognosis. null Methods: To further define diagnostic features and to establish clinical correlations, 73 GZL cases diagnosed at 15 North American academic centers (62 cases from...
Paper Details
Title
Gray Zone Lymphoma (GZL) with Features Intermediate between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): A Pathologic Consensus Study with Patient Outcomes and Prognostication across 15 North American Centers
Published Date
Dec 7, 2017
Journal
Volume
130
Pages
375 - 375
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History